Business Daily Media

Business Marketing

Biogen Plans Regulatory Filing for Aducanumab in Alzheimer's Disease Based on New Analysis of Larger Dataset from Phase 3 Studies

  • Written by ACN Newswire - Press Releases

image

TOKYO, Oct 23, 2019 - (JCN Newswire) - Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd. (Tokyo, Japan) has announced that, after consulting with the U.S. Food and Drug Administration (FDA), Biogen plans to pursue regulatory approval for aducanumab, an investigational treatment for early Alzheimer's disease (AD). The Phase 3 EMERGE Study met its primary

Read more //?#

Popular

iCAR ASIA LAUNCHES FIRST VIRTUAL EXPO IN INDONESIA

Mobil123.com, the Number 1 Automotive Portal in Indonesia, is to hold the first ever Mobil123 DRIVE Virtual Expo 2020 from July 25 – 2 August 2020. Responding to the new normal the Mobil123 DRIVE Virtual Expo 2020 is an a...

Personal, not professional, social networks will be key to hiring top Gen Z talent

HireVue, the global leader in video interviewing, assessments, and text-enabled recruiting tools reveals job seekers are increasingly turning to non-professional social media platforms such as Facebook, Instagram and TikTok in...

Australian SMBs’ interested in AI but greater education, support needed - Zoho research

Small and medium-sized businesses (SMBs) in Australia are showing a growing interest in adopting new categories of artificial intelligence (AI), particularly generative AI, to improve efficiency, reduce costs, and make data-dr...

Virtual Office
Tomorrow Business Growth